Early trial results show stapokibart improves paediatric atopic dermatitis with good tolerability. Find out more about its ...

An international team of investigators has reported results from the first Phase III clinical trials of rocatinlimab, a novel ...

High blood pressure is often described as a silent threat inside the body. People typically connect it with heart attacks or ...

Eczema, a chronic skin condition causing itching and inflammation, affects people of all ages. It manifests in various forms like atopic dermatitis and contact dermatitis, often triggered by allergens ...

If approved, EBGLYSS would be a first-line biologic that offers the option of monotherapy with once every eight-week maintenance dosing in moderate-to-severe atopic dermatitis uncontrolled by topicals ...

And the folks, I'm chief meteorologist RB Bobby, the 4029tv.com forecast on this Thursday, October 16th, another warm day, another quiet day, but it will not stay quiet all the way through the weekend ...

The MarketWatch News Department was not involved in the creation of this content. TORONTO, Sept. 25, 2025 /CNW/ - Today, Eli Lilly Canada Inc.'s ("Lilly") Ebglyss(R) (lebrikizumab) to treat ...

SAN FRANCISCO and BOSTON, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for ...

Amgen Inc. (NASDAQ:AMGN) and Kyowa Kirin released preliminary topline results from the ASCEND study evaluating rocatinlimab in adults and adolescents with moderate to severe atopic dermatitis (AD) on ...

Dr. Chelsea Dorsey discusses chronic venous insufficiency (CVI) as a debilitating, underdiagnosed disease with high costs and limited treatments, highlighting bioprosthetic venous valves as a ...

Lilo & Stitch actor David Hekili Kenui Bell died on June 12 at the age of 46. The autopsy was performed on June 19 and concluded on July 10. The report revealed that medical intervention was attempted ...